<DOC>
	<DOCNO>NCT01317069</DOCNO>
	<brief_summary>Through clinical practice , explore application Fluorouracil implant could effectively delay local tumor recurrence improvement postoperative survival time patient gallbladder cancer bile duct cancer .</brief_summary>
	<brief_title>A Randomized , Open , Prospective Clinical Research Fluorouracil Implant Improve Surgical Gallbladder Cancer Bile Duct Cancer</brief_title>
	<detailed_description>Major Objective Through clinical practice , explore application Fluorouracil implant could effectively delay local tumor recurrence improvement postoperative survival time patient gallbladder cancer bile duct cancer . Secondary objective 1 ) If Fluorouracil implant application clinical surgery could lead incidence complication increase biliary-enteric anastomosis . 2）Assess drug safety accord drug-related clinical / laboratory adverse event . 3）Observe postoperative complication rate Fluorouracil implant . 4）Observe quality life patient use Fluorouracil implant .</detailed_description>
	<mesh_term>Gallbladder Neoplasms</mesh_term>
	<mesh_term>Bile Duct Neoplasms</mesh_term>
	<mesh_term>Fluorouracil</mesh_term>
	<criteria>The patient gallbladder bile duct cancer diagnosis surgical exploration , intraoperative frozen biopsy ( Annex 2 ) . Aged 18 70 year old , male female , body condition score generally ECOG 0～2 , expect survival ≥ 3 month . Subjects major organ dysfunction , blood , liver , kidney heart function normal , specific requirement laboratory indicator : Blood : WBC count &gt; 3.0 × 109 / L , Platelet count &gt; 100 × 109 / L , Hb &gt; 8.0g/dl . Liver function：serum bilirubin less 1.5 time upper limit normal ; ALT AST less 3 time upper limit normal . Renal function : creatinine le 1.5 time upper limit normal . Participants use chemotherapy drug , subject 30day washout period proceed test . Patients anaphylactic reaction oxaliplatin fluorouracil past . Patients understand circumstance study sign informed consent . Currently receive effective treatment； Pregnancy , breastfeed patients； Primary brain tumor central nervous system metastatic tumor control ; Patients receive chemotherapy , radiotherapy , biological therapy , drug instrument therapy 30 day enrollment . Patients purulent chronic infect wound delay heal . Patients liver , kidney heart failure coronary heart disease , angina , myocardial infarction , arrhythmia , cerebral thrombosis , stroke serious cardiovascular cerebrovascular disease ; Patients history mental illness difficult control ; Patients consider inappropriate participate trial researcher .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>70 Years</maximum_age>
	<verification_date>March 2011</verification_date>
</DOC>